Fibroblast growth factor 23 and symmetric dimethylarginine concentrations in geriatric cats

BACKGROUND: Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that is increased in azotemic cats with chronic kidney disease (CKD) and predictive of the onset of azotemia in older cats. The introduction of symmetric dimethylarginine (SDMA) as a biomarker of glomerular filtration rate has...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Vet Intern Med
Autors principals: Sargent, Hannah J., Jepson, Rosanne E., Chang, Yu‐mei, Biourge, Vincent C., Bijsmans, Esther S., Elliott, Jonathan
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2019
Matèries:
SMALL ANIMAL
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6872607/
https://ncbi.nlm.nih.gov/pubmed/31568615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.15590
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars